#OriginalResearch: Transfemoral #TAVR compared with #SAVR - cost savings at 2 years in patients with Low Surgical Risk #AorticStenosis - Data from PARTNER 3 Howard Herrmann Samir Kapadia Benjamin Galper David J. Cohen, MD, MSc #AHAJournals ahajournals.org/doi/10.1161/CI…

Dr. David Cohen’s Top 10 high yield Interventional Cardiology trials. Published years ago, but still very relevant and laid the foundation of what we do today. #Fellows2023 Cardiovascular Research Foundation

#ICYMI: Cost-effectiveness of TAVR in Low-Risk Patients Howard Herrmann Samir Kapadia @bgalperMD David J. Cohen, MD, MSc #AHAJournals

#TVT2023 kicks off with two focused & interactive programs. Don't miss out on the chance to engage with & learn from esteemed experts! ow.ly/oXjY50OGZOf ✨Structural Heart Disease #Imaging: Anatomy, Guidance, & Technical Outcomes ✨iCOACH EC: A Practical Tutorial for

So excited for this big moment for Structural Heart even more reason for you to submit your exciting research to the premier structural heart disease journal. It is such an honor to serve as an associate editor and to work with such an amazing group of editors!

Excited for TVT 2023 to get underway. iCOACH EC this morning great opportunity for fellows and EC to engage in key aspects to ensure procedural success. Looking forward to speaking with Vivian Ng Raj Tayal on femoral access in TAVR. Should be a great meeting! Cardiovascular Research Foundation

Excellent session on vascular closure & complication bailout methods. Broad range of discussion from transfemoral/transaxillary access to equipment to familiarize oneself with should a complication arise. Cardiovascular Research Foundation TCTMD TCT Conference Raj Tayal Benjamin Galper Vivian Ng #tvt2023

#ICYMI: Structural Heart, the official journal of Cardiovascular Research Foundation, is indexed in PubMed Central! Researchers and institutions worldwide can now access and read articles. ow.ly/sMW650OHk6Z #CardioTwitter #TVT2023 Elsevier Cardiology Juan F. Granada Maria Alu G. Burkhard Mackensen Benjamin Galper

A new study authored by Benjamin Galper shows transcatheter aortic valve replacement (TAVR) procedures greatly improve patients' quality of life. "The median hospital stay was two days for TAVR and six days for open-heart surgery," says Dr. Galper. Learn more: k-p.li/3po8gzA

Surprise cake today after our 800th TAVR. Thx Megan best coordinator ever! Proud to work with an incredible team to help so many amazing patients. The force is strong in our program. Mid-Atlantic Permanente Medicine LIFE AT VHC Health Happy TAVR 800! Natalia Berry MD MBA Preston Perrin Ameya Kulkarni, MD

The story of a complex BASILICA TAVR patient who went on to win the gold medal in pickle ball at the senior Olympics. Honored to work with an incredible team to give life back to amazing patients. Mid-Atlantic Permanente Medicine Kaiser Permanente LIFE AT VHC Health TAVR Bot mydoctor.kaiserpermanente.org/mas/video/how-…

12:30pm today in iCoach theater don’t miss an incredible panel on reasons for and consequences of delays in referral to TAVR. We will be tackling why only 50% of patients with severe AS get referred for life saving TAVR procedures. Join us room 203 TCT Conference Edwards Lifesciences

Excited to present results of our TAVR Delay study today at 11am TCT Conference Lots of work to do to ensure all eligible patients receive TAVR. Mid-Atlantic Permanente Medicine is poised to take on the challenge. Natalia Berry MD MBA Honored our work featured in Cath Lab Digest hmpgloballearningnetwork.com/site/cathlab/m…

TAVR procedures are likely to become the gold standard of care for patients with severe aortic stenosis, but TAVR is not being disseminated as widely as it should be. But why? Benjamin Galper's new research seeks to answer that question: k-p.li/46ew9J7

Heart disease is the #1 killer of women in the U.S. — but symptoms present differently in women than they do in men. Benjamin Galper and his patient Tookie Gentilcore spoke with @WJZ about what women should know. cbsn.ws/3OBHltC

Honored to raise awareness of heart disease in women alongside Tookie our incredible TAVR patient. Mid-Atlantic Permanente Medicine we diagnose and treat heart disease efficiently so our patients get back to activities quickly and live longer. Kaiser Permanente #HeartMonth cbsnews.com/baltimore/vide…

🌟 The future of valvular and structural heart disease is at #NYValves2024! Join us as we redefine innovation and multidisciplinary collaboration in structural heart care. 🫀💡 Take advantage of early-bird pricing! Rates go up on April 4. nyvalves2024.crfconferences.com/register #CardioTwitter

🄽🄴🅆 🅈🄾🅁🄺 🅅🄰🄻🅅🄴🅂 🗓️JUNE 5-7, 2024 📍JACOB K. JAVITS CONVENTION CENTER 🔗Early bird registration: nyvalves2024.crfconnect.com/register 🎓Fellows free registration #NYValves2024 Salvatore Brugaletta Aditya Bharadwaj Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 Atul Mathur Samir Kapadia Hany Ragy Nicole Karam, MD, PhD, FESC Colum Owens

Honored to be involved in this incredible study demonstrating that next day discharge after TAVR is not only safe but may lead to decreased readmission and mortality. Thx Wayne Batchelor, MD for including me in this great project. Kendra J. Grubb M.D. Carlos E. Sanchez MD TAVR Bot

Welcome to Mid-Atlantic Permanente Medicine Noah Haroian, MD PharmD Rajeev Samtani. Excited for you to join our cardiology group and I can’t imagine better new partners for our structural heart team. No better first day than TAVR Tuesday! Dr. Gilbert Tang Ameya Kulkarni, MD TAVR Bot John Forrest Amit N. Vora, MD MPH